141 related articles for article (PubMed ID: 32147980)
21. Incidence and treatment of ductal carcinoma in situ of the breast.
Silverstein MJ
Eur J Cancer; 1997 Jan; 33(1):10-1. PubMed ID: 9071892
[No Abstract] [Full Text] [Related]
22. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of primary non-metastatic breast cancer: A single institution experience.
Jamshed A; Shah MA; Syed AA; Murtaza G; Mehmood T; Chaudry SJ; Loya A; Hameed S
Indian J Cancer; 2015; 52(1):119-25. PubMed ID: 26837998
[TBL] [Abstract][Full Text] [Related]
24. Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution.
Zhou FF; Xia LP; Wang X; Guo GF; Rong YM; Qiu HJ; Zhang B
Chin J Cancer; 2010 Feb; 29(2):184-8. PubMed ID: 20109348
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of male breast cancer in our department during a 5-year period].
Cseh I; Kerekes M; Solymosi T
Magy Seb; 2011 Jun; 64(3):112-5. PubMed ID: 21672681
[TBL] [Abstract][Full Text] [Related]
26. Cancer of the male breast.
Sandler B; Carman C; Perry RR
Am Surg; 1994 Nov; 60(11):816-20. PubMed ID: 7978672
[TBL] [Abstract][Full Text] [Related]
27. [Breast cancer in men: about 40 cases and literature review].
Elbachiri M; Fatima S; Bouchbika Z; Benchekroun N; Jouhadi H; Tawfiq N; Sahraoui S; Benider A
Pan Afr Med J; 2017; 28():287. PubMed ID: 29675121
[TBL] [Abstract][Full Text] [Related]
28. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH
Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
[TBL] [Abstract][Full Text] [Related]
29. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
30. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological study of male breast cancer in Nigerians and a review of the literature.
Olu-Eddo AN; Momoh MI
Nig Q J Hosp Med; 2010; 20(3):121-4. PubMed ID: 21033319
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
33. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
34. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
[TBL] [Abstract][Full Text] [Related]
35. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of male breast cancer.
Lanitis S; Rice AJ; Vaughan A; Cathcart P; Filippakis G; Al Mufti R; Hadjiminas DJ
World J Surg; 2008 Nov; 32(11):2471-6. PubMed ID: 18787895
[TBL] [Abstract][Full Text] [Related]
38. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
[TBL] [Abstract][Full Text] [Related]
39. [Male breast cancer--our experience].
Fiala L; Coufal O; Fait V; Foretová L
Rozhl Chir; 2010 Oct; 89(10):612-8. PubMed ID: 21374944
[TBL] [Abstract][Full Text] [Related]
40. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
